Solid Biosciences (SLDB) Shares Outstanding (2017 - 2024)
Solid Biosciences' Shares Outstanding history spans 8 years, with the latest figure at $38.9 million for Q3 2024.
- For Q3 2024, Shares Outstanding rose 94.05% year-over-year to $38.9 million; the TTM value through Sep 2024 reached $38.9 million, up 94.05%, while the annual FY2023 figure was $20.4 million, 4.24% up from the prior year.
- Shares Outstanding for Q3 2024 was $38.9 million at Solid Biosciences, up from $38.6 million in the prior quarter.
- Across five years, Shares Outstanding topped out at $112.4 million in Q1 2021 and bottomed at $5.8 million in Q4 2020.
- The 5-year median for Shares Outstanding is $20.0 million (2023), against an average of $27.6 million.
- The largest annual shift saw Shares Outstanding tumbled 93.31% in 2022 before it soared 166.32% in 2023.
- A 5-year view of Shares Outstanding shows it stood at $5.8 million in 2020, then grew by 29.23% to $7.5 million in 2021, then surged by 160.76% to $19.6 million in 2022, then grew by 4.24% to $20.4 million in 2023, then surged by 90.96% to $38.9 million in 2024.
- Per Business Quant, the three most recent readings for SLDB's Shares Outstanding are $38.9 million (Q3 2024), $38.6 million (Q2 2024), and $37.8 million (Q1 2024).